Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by RapsAloton Nov 09, 2020 6:50pm
183 Views
Post# 31867605

Head Office Relocation

Head Office Relocation
Change of Head Office of the Corporation 
As a result of certain changes to members of the Board and management of the Corporation, the 
Corporation has developed a stronger nexus to Ontario than Quebec. Accordingly, at the Meeting, 
Shareholders will be asked to consider, and if deemed advisable, to approve a special resolution 
(the “Head Office Change Resolution”) to authorize an amendment to the articles of the Corporation to 
modify the location of the head office of the Corporation from Montral, Quebec to Toronto, Ontario (the 
“Change of Head Office”). 
The Board and management of the Corporation, after careful consideration of a number of factors, has 
determined that the Change of Head Office is in the best interests of the Corporation and its Shareholders 
and authorized the submission of the Change of Head Office to Shareholders for approval by special 
resolution at the Meeting. The Change of Head Office Resolution must be passed, with or without 
variation, by at least two-thirds of the votes cast by the Shareholders present in person or by proxy at the 
Meeting. Accordingly, at the Meeting, Shareholders will be asked to approve the following special 
resolution approving the Change of Head Office: 
“BE IT RESOLVED AS A SPECIAL RESOLUTION THAT: 
 
1. the head office of the Corporation be changed from Montral, Quebec to Toronto, 
Ontario; 
2. the articles of the Corporation be amended to reflect the foregoing; 
3. the Board be and is authorized to file articles of amendment and all other requisite 
documents with all applicable regulatory authorities in order to give effect to the change 
of the head office of the Corporation; 
4. notwithstanding the passage of this resolution by the shareholders of the Corporation, the 
Board may, without any further notice or approval of the shareholders of the Corporation, 
decide not to proceed with the change of the head office of the Corporation or to 
otherwise give effect to this resolution at any time prior to the change of the head office of 
the Corporation becoming effective and may revoke this resolution without further 
approval of the shareholders at any time prior to the completion of the transactions 
authorized by this resolution; and 
5. any one or more of the directors or officers of the Corporation is hereby authorized and 
directed, acting for, in the name of and on behalf of the Corporation, to execute or cause 
to be executed, under the seal of the Corporation or otherwise, and to deliver or cause to 
be delivered, such other documents and instruments, and to do or cause to be done all 
such other acts and things, as may in the opinion of such director or officer of the 
Corporation be necessary or desirable to carry out the intent of the foregoing resolution, 
the execution of any such document or the doing of any such other act or thing by any 
director or officer of the Corporation being conclusive evidence of such determination, 
provided such actions are carried out within the limit of the law.” 
THE BOARD RECOMMENDS THAT SHAREHOLDERS VOTE IN FAVOUR OF THE HEAD OFFICE 
CHANGE RESOLUTION.
PROXIES RECEIVED IN FAVOUR OF MANAGEMENT WILL BE VOTED FOR THE HEAD OFFICE 
CHANGE RESOLUTION, UNLESS THE SHAREHOLDER HAS SPECIFIED IN THE PROXY THAT HIS 
OR HER COMMON SHARES ARE TO BE VOTED AGAINST SUCH RESOLUTION. 
Election of Directors
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse